Overview
- This week’s coverage summarizes a May 19 study published in Alzheimer's & Dementia that analyzed blood and sleep data from 2,410 Framingham Heart Study participants.
- Researchers used flexible non-linear models and found plasma phosphorylated tau 181 (p-tau181), an Alzheimer’s-related blood biomarker, rose starting at about 8.5–9 hours of habitual sleep and climbed most steeply past 10 hours.
- The association between long sleep and higher p-tau181 remained after adjusting for age, sex, sleep apnea, depression, APOE ε4 genotype, and kidney function, while links for other neurodegeneration markers disappeared when kidney function was included.
- Authors and lead researcher Vanessa M. Young emphasize the study is cross-sectional so it cannot prove long sleep causes Alzheimer’s; they recommend clinicians note prolonged sleep and call for prospective, longitudinal studies to test timing and causality.
- The finding matters because plasma biomarkers now allow large population analyses and, if validated, long nightly sleep could become an easy behavioral signal to prompt earlier clinical evaluation or monitoring for cognitive decline.